Related Experiment Videos
Levels of complement components during allergen-induced asthma
Clinical Allergy
|January 1, 1978
Summary
Investigating allergen-induced asthma, this study found no evidence of complement system activation in patient blood samples. Complement components C3, C4, and CH50 levels remained unchanged, indicating no complement involvement during asthma attacks.
Area of Science:
- Immunology
- Respiratory Medicine
- Allergy Research
Background:
- Allergen-induced asthma involves complex immune responses.
- The complement system plays a role in inflammation and immunity.
- Its specific role in acute asthma exacerbations requires further elucidation.
Purpose of the Study:
- To investigate the activation status of the complement system during allergen-induced asthma.
- To quantify levels of key complement components (C3, C4) and total hemolytic complement (CH50).
Main Methods:
- Peripheral blood samples were collected from patients experiencing allergen-induced asthma.
- Levels of complement components C3 and C4 were measured.
- Total hemolytic complement activity (CH50) was assessed.
- Evidence of complement activation was sought.
Main Results:
- No evidence of complement system activation was detected in the studied samples.
- Circulating levels of C3 and C4 remained within normal ranges.
- Total hemolytic complement (CH50) activity showed no significant changes.
Conclusions:
- The complement system does not appear to be activated during allergen-induced asthma attacks.
- These findings suggest that complement activation is not a primary mechanism in this asthma model.
- Further research may explore other inflammatory pathways involved in asthma.